MAXICARE HEALTH PLANS INC
8-K, 1994-08-08
HOSPITAL & MEDICAL SERVICE PLANS
Previous: SMITH INTERNATIONAL INC, 8-K/A, 1994-08-08
Next: FIDELITY ADVISOR SERIES I, 13F-E, 1994-08-08









                                   UNITED STATES

                        SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, D.C. 20549

                                     FORM 8-K

                                  CURRENT REPORT






        Pursuant to Section 13 OR  15(d)  of The Securities Exchange Act of
        1934


        Date of Report (Date  of  earliest  event reported) With respect to
        Item 5. - July 29, 1994.  With respect to Item 4. - August 1, 1994.




                           MAXICARE HEALTH PLANS, INC.                     
               (Exact name of registrant as specified in its charter)




                 Delaware                0-12024           95-3615709      
        (Name or other jurisdiction    (Commission      (IRS Employer
            of incorporation)          File Number)     Identification No.)



<PAGE>


          1149 South Broadway Street, Los Angeles, California    90015     
          (Address of principal executive offices)             (Zip Code)




        Registrant's telephone number, including area code  (213) 765-2000 




                              Exhibit Index at 5 of 6

                                      1 of 6
        <PAGE>
        Item 4.  Changes in Registrant's Certifying Accountants.

            (a)  Previous independent accountants

                 On August 1, 1994 Maxicare Health Plans, Inc. ("Maxicare")
                 dismissed Price Waterhouse as its independent accountants.

                 The  reports  of  Price  Waterhouse  on  the  consolidated
                 financial statements for the  past  two years contained no
                 adverse opinion  or  disclaimer  of  opinion  and were not
                 qualified or modified  as  to  uncertainty, audit scope or
                 accounting principles.

                 Maxicare's Audit  Committee  participated  in and approved
                 the decision to change independent accountants.

                 In connection with  its  audits  for  the  two most recent
                 years and  through  August  1,  1994,  there  have been no
                 disagreements  with  Price  Waterhouse  on  any  matter of
                 accounting principles  or  practices,  financial statement
                 disclosure,  or   auditing   scope   or  procedure,  which
                 disagreement(s), if not  resolved  to  the satisfaction of
                 Price Waterhouse, would have caused them to make reference
                 to  the  subject   matter   of   the  disagreements(s)  in
                 connection with their reports.

                 Maxicare has requested  that  Price  Waterhouse furnish it
                 with a letter  addressed  to  the  Securities and Exchange
                 Commission stating whether or not it agrees with the above
                 statements.  A copy of  such  letter, dated August 5, 1994
                 is filed as Exhibit 16 to this Form 8-K.

            (b)  New independent accountants

                 Maxicare engaged  Ernst  &  Young  as  its new independent
                 accountants as of August  5,  1994.    During the two most
                 recent fiscal years  and  through  August 1, 1994 Maxicare
                 has  not  consulted  with  Ernst  &  Young  regarding  the
                 application  of  accounting   principles  to  a  specified
                 transaction, either completed or  proposed; or the type of
                 audit  opinion  that  might   be  rendered  on  Maxicare's
                 financial statements,  and  neither  a  written report was
                 provided to Maxicare nor oral advice provided that Ernst &
                 Young concluded  was  an  important  factor  considered by
                 Maxicare in  reaching  a  decision  as  to the accounting,
                 auditing or financial reporting  issue; or any matter that
<PAGE>


                 was either the subject  of  a  disagreement (as defined in
                 Regulation  S-K   Item   304(a)(1)(iv)   and  the  related
                 instructions to  this  item)  or  a  reportable  event (as
                 described in Regulation S-K Item 304(a)(1)(v)).

                                      2 of 6
        <PAGE>
        Item 5.  Other Events

                 Maxicare  Health  Plans,  Inc.  realized  net  proceeds of
                 approximately   $4.2   million   from   the   exercise  of
                 outstanding warrants  in  connection  with  its previously
                 announced warrant redemption which was consummated on July
                 29,  1994.      Prior   to   the   redemption  there  were
                 approximately 555,000 warrants  outstanding. In accordance
                 with the  terms  of  the  Warrant Agreement, approximately
                 420,000 of the Company's  warrants were exercised at $9.98
                 per warrant.    All  former  warrant  holders  who did not
                 exercise  their  warrants  are  entitled  to  receive  the
                 redemption price of $.05  per  share  upon tender of their
                 certificates to the warrant agent, American Stock Transfer
                 & Trust Company.















                                      3 of 6
        <PAGE>
                                    SIGNATURES




             Pursuant to the requirements of the Securities Exchange Act of
        1934, the registrant has duly  caused  this  report to be signed on
        its behalf by the undersigned thereunto duly authorized.




                                      Maxicare Health Plans, Inc.
                                            (Registrant)


        August 5, 1994                By  /s/ EUGENE L. FROELICH  
                                         Eugene L. Froelich
                                         Chief Financial Officer
                                         and Executive Vice President -
                                         Finance and Administration

<PAGE>


                                      4 of 6
        <PAGE>
                                  INDEX TO EXHIBITS



        Exhibit                                                 Sequential
        Number    Description                                   Page Number

          16      Letter re change in certifying accountant      6 of 6



















                                       5 of 6

                                                      EXHIBIT 16


        August 5, 1994


        Securities and Exchange Commission
        450 Fifth Street, N.W.
        Washington, D.C.  20549



        Dear Sirs:


                           MAXICARE HEALTH PLANS, INC.


        We have read Item  4  of  Maxicare  Health Plans, Inc.'s Form 8-K
        dated August 1, 1994  and  are  in  agreement with the statements
        contained in paragraph 4(a) therein.




        Sincerely,
<PAGE>


        /s/ PRICE WATERHOUSE



















                                     6 of 6


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission